Biswajyoti Sahu

Biswajyoti Sahu is a Research Professor and Group Leader of the Precision Cancer Epigenomics laboratory at the Nordic-EMBL Partnership Institute (NCMBM), University of Oslo. He also holds an Adjunct Professor position in Molecular Genetics at the University of Helsinki. His research focuses on understanding the role of gene regulatory elements, particularly enhancers, in cancer and enhanceropathies, alongside mechanisms of epigenome reprogramming and lineage-specific oncogenesis. He employs cutting-edge technologies like single-cell genomics, CRISPR-Cas9, and functional genomics to study transcription factor networks and chromatin dynamics.

Education:

• PhD in Biomedicine and Cancer Research, University of Helsinki (2012)
• MSc in Molecular Biology and Human Genetics, Banaras Hindu University (2003)

Research Interests:

• Lineage-specific transcription factors in cancer progression
• Epigenetic plasticity and transposable elements in oncogenesis
• Single-cell and multi-omics approaches for cancer diagnosis
• Functional genomics and precision medicine targeting gene regulatory elements

Awards:

• Docent in Molecular Genetics (2020)
• Academy of Finland Research Fellowship (2018–2023)
• Early-career Investigator Award (2018)

Labs & Collaborations: Leads a 14-member lab in Oslo and Helsinki, collaborating with institutions on epigenetic reprogramming and cancer genomics. His work is funded by the Norwegian Cancer Society and the Center for Molecular Medicine Norway.